Sorrento Therapeutics Inc (SRNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRNE | AZN | AMGN | GILD | BMY |
| Company | Sorrento Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.0035 | 94.64 | 328.11 | 123.10 | 56.56 |
| High | 0.0041 | 94.64 | 328.11 | 123.10 | 56.56 |
| Low | 0.0035 | 94.64 | 328.11 | 123.10 | 56.56 |
| Latest | 0.0035 | 94.64 | 328.11 | 123.10 | 56.56 |
| Change | -0.0005 | +0.65 | -1.92 | +1.84 | -0.06 |
| % Change | -12.50% | +0.69% | -0.58% | +1.52% | -0.10% |
| Volume | 17,200 | 65,839 | 1,564 | 34,072 | 8,423 |
| 20-Day Average Volume | 521,130 | 5,113,477 | 2,547,563 | 5,875,559 | 13,634,021 |
| Previous Close | 0.0040 | 93.99 | 330.03 | 121.26 | 56.62 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0029 | 93.13 | 329.03 | 122.82 | 54.97 |
| 20-Day Raw Stochastic | 32.99% | 73.21% | 39.86% | 59.07% | 90.41% |
| 20-Day Relative Strength | 48.62 | 58.20 | 51.18 | 51.27 | 65.55 |
| Weighted Alpha | +151.22 | +44.94 | +20.90 | +29.59 | +10.12 |
| Today's Opinion | 24% Sell | 100% Buy | 48% Buy | 64% Buy | 100% Buy |
| Previous Opinion | 16% Sell | 100% Buy | 80% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 8% Buy | 100% Buy | 72% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +25.00% since 01/08/26 | -0.01% since 01/09/26 | +0.62% since 01/09/26 | +1.65% since 01/09/26 | +1.26% since 01/09/26 |
| Low | 0.0004 on 01/13/26 | 92.78 on 01/13/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 55.33 on 01/15/26 |
| High | 0.0047 on 01/14/26 | 96.43 on 01/14/26 | 332.50 on 01/15/26 | 124.57 on 01/15/26 | 57.04 on 01/14/26 |
| 1-Month | |||||
| %Chg | -10.26% since 12/15/25 | +3.60% since 12/16/25 | +0.42% since 12/16/25 | +3.64% since 12/16/25 | +4.30% since 12/16/25 |
| Low | 0.0003 on 12/31/25 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 0.0100 on 01/08/26 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 57.04 on 01/14/26 |
| 3-Month | |||||
| %Chg | -50.00% since 10/15/25 | +12.90% since 10/16/25 | +10.92% since 10/16/25 | +4.45% since 10/16/25 | +30.36% since 10/16/25 |
| Low | 0.0003 on 12/31/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 0.0160 on 10/31/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| 6-Month | |||||
| %Chg | +150.00% since 07/15/25 | +35.05% since 07/16/25 | +9.73% since 07/16/25 | +12.06% since 07/16/25 | +19.91% since 07/16/25 |
| Low | 0.0002 on 08/12/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 42.52 on 10/29/25 |
| High | 0.0985 on 09/04/25 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 57.04 on 01/14/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,929 | 291,505,472 | 177,714,880 | 150,444,864 | 115,264,336 |
| Shares Outstanding, K | 551,280 | 3,101,452 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 62,840,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -572,840,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 15,030,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -95,210,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 1.23 | 0.34 | 0.45 | 0.33 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 1.63 on 10/30/25 |
| Latest Earnings Date | 10/04/24 | 02/10/26 | 02/03/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.08 | 15.04 | 15.15 | 8.69 |